Top Markets
Coin of the day
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DPH
Classifica tra le azioni #24497
Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the... Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.
Prezzo delle azioni
$52.60
Ultima sincronizzazione: 2024-01-15
Capitalizzazione di mercato
$59.92M
Variazione (1 giorno)
6.81%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Dechra Pharmaceuticals PLC (DPH)

Categoria

Il prezzo DPH con la capitalizzazione del mercato della B
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
DPH
$52.60
Capitalizzazione di mercato di Dechra Pharmaceuticals PLC(DPH)
Capitalizzazione di mercato: $59.92M
A partire dal August 2026, Dechra Pharmaceuticals PLC ha una capitalizzazione di mercato pari a $59.92M. Questo rende Dechra Pharmaceuticals PLC la 24497th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Dechra Pharmaceuticals PLC dal 2000 al 2026
DPH in paragone con la classifica dei più popolari stocks
Il prezzo per DPH Attivo B Capitalizzazione del mercato a B Risultati
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$4,574,232 $59.92M
$5.210T +8,695,377.77%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,980,979 $59.92M
$4.535T +7,567,622.30%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,641,476 $59.92M
$4.148T +6,922,236.79%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,142,068 $59.92M
$3.579T +5,972,876.63%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$2,439,438 $59.92M
$2.779T +4,637,198.92%